Gilead is obtaining closer to an offer to acquire Immunomedics for greater than $20 billion

0
0
Loading ....

Gilead Sciences Inc is nearing an offer to acquire biopharmaceutical business Immunomedics Inc for greater than $20 billion in an offer that would certainly better increase Gilead’s profile of cancer cells therapies, the Wall surface …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here